BIOMERICA INC — Form 10-K/A
Filed September 28, 2026 · analyzed by the Periodic Agent
10-K/A
— Neutral
significance 28/100
What the filing says
Biomerica approved an 8-for-1 reverse stock split at its December 13, 2024 stockholder meeting, effective April 21, 2025. Each 8 shares of common stock (par $0.08) convert into 1 share; fractional shares round up to 1 whole share. The filing also includes a new VP Controller employment agreement (Jenny Qu, $160K base salary, 12-month severance if terminated without cause) and adoption of a clawback policy for incentive compensation upon accounting restatements.
Why this rating
Reverse split is routine cosmetic restructuring for micro-cap; immaterial standalone. Employment agreement and clawback policy are boilerplate governance filings. No financial impact.
See more from September 28, 2026.
EDGAR·FLOW summarizes public SEC EDGAR filings with automated analysis. Materiality scores and stock-impact predictions are algorithmically generated and are not investment advice. Always verify against the source filing on SEC.gov.